Caxton Associates LP Emergent Bio Solutions Inc. Transaction History

Caxton Associates LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.35 - $13.21 $181,309 - $325,864	-24,668 Reduced 32.92%	50,265 $369,000
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $482,263 - $1.01 Million	61,908 Added 475.3%	74,933 $776,000
Q4 2022 Feb 14, 2023	SELL	$11.0 - $21.45 $42,977 - $83,805	-3,907 Reduced 23.07%	13,025 $153,000
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $4,279 - $7,625	213 Added 1.27%	16,932 $355,000
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $458,434 - $729,449	16,719 New	16,719 $519,000
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $208,771 - $293,946	-2,637 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$81.91 - $134.94 $311,012 - $512,367	-3,797 Reduced 59.01%	2,637 $272,000
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $349,559 - $575,971	6,434 New	6,434 $509,000

187

39.4M

277K

151K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $444M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.